SESSION 1904-1905.Stankovic, Tijana; Milinkovic, Vedrana; Bankovic, Jasna; Dinic, Jelena; Tanic, Nasta; Dramicanin, Tatjana; Tanic, Nikola · The Lancet · 1904

Anti-cancer Drugs - Nature, Synthesis and Cell || Potential Anticancer Drugs Targeting Immune PathwaysBankovic, Jasna · 2016

Mutual regulation and targeting of multidrug resistance and cancer stem phenotypePodolski-Renic, Ana; Milosevic, Zorica; Dinic, Jelena; Stankovic, Tijana; Bankovic, Jasna; Pesic, Milica · Med. Chem. Commun. · 2016

Elucidation and in planta reconstitution of the parthenolide biosynthetic pathwayLiu, Qing; Manzano, David; Tanić, Nikola; Pesic, Milica; Bankovic, Jasna; Pateraki, Irini; Ricard, Lea; Ferrer, Albert; de Vos, Ric; de Krol, Sander van; Bouwmeester, Harro · Metabolic Engineering · 2014

Anti-cancer Drugs - Nature, Synthesis and Cell || Natural Products for Treatment of Chronic Myeloid LeukemiaBankovic, Jasna · 2016

Genomic instability and p53 alterations in patients with malignant gliomaVedrana Milinkovic; Jasna Bankovic; Miodrag Rakic; Nebojsa Milosevic; Tijana Stankovic; Milos Jokovic; Zorica Milosevic; Milica Skender-Gazibara; Ana Podolski-Renic; Milica Pesic; Sabera Ruzdijic; Nikola Tanic · 2012

Anti-cancer Drugs - Nature, Synthesis and Cell || SHetA2, a New Cancer-Preventive Drug CandidateBankovic, Jasna · 2016

Identification of genes associated with non-small-cell lung cancer promotion and progressionBankovic, Jasna; Stojsic, Jelena; Jovanovic, Dragana; Andjelkovic, Tijana; Milinkovic, Vedrana; Ruzdijic, Sabera; Tanic, Nikola · Lung Cancer · 2010